Grifols S.A.

History

Year	Detail
1909	The company was founded and first clinical analysis laboratory was established.
1945	The first private blood bank and plasma bank in Spain is established through freeze-drying as a technique.
1958	Company's first plasma fractionation plant is opened in Barcelona.
1960	The company ventures into North America through partnership with Dade Reagents.
1972	The company expands its production plant in Barcelona for plasma fractionation, parenteral fractionation, and scientific instrumentation.
1988	The company opens subsidiary in Portugal marking its first international expansion.
1995	The company is awarded FDA licence for its installation and biological plant, Albumin.
2002	The company acquired SeraCare and its 43 plasma donation centers in U.S.
2003	The company acquired Alpha Therapeutic Corporation-Mitsubishi, and its plasma fractionation plant in California.
2006	The company was listed on Spanish Stock Exchange and IBEX35.
2011	The company acquired Talecris Biotherapeutics and became the largest manufacturer of plasma-derived medicines in World.
2018	The company acquired Haema expanded its network of plasma donation centers outside U.S.
2022	The company acquired Biotest and acquired a production plant in Dreieich (Germany) and a network of plasma donation centers in Germany, Hungary and the Czech Republic.